News

Filter

Current filters:

None

1 to 9 of 96573 results

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

23-10-2014

The recent US Food and Drug Administration approval of Harvoni (ledipasvir/sofosbuvir), Gilead Sciences’…

Anti-viralsBiotechnologyGilead SciencesHarvoniMarkets & MarketingPricingSovaldi

Europe’s pharma regulator moves further to push Ebola treatments development

23-10-2014

During the past months, the European Medicines Agency has put in place a system to give the best possible…

Anti-viralsEuropePharmaceuticalRegulationResearchVaccines

Mylan and Abbott amend terms of their $5.3 billion deal

Mylan and Abbott amend terms of their $5.3 billion deal

23-10-2014

US generic drugmaker Mylan and US drugmaker Abbott Laboratories have revised the pricing terms of their…

AbbottAbbott LaboratoriesGenericsMergers & AcquisitionsUSA

Cost of Australian PBS rises below rate of inflation for 2013-2014

Cost of Australian PBS rises below rate of inflation for 2013-2014

23-10-2014

The Australian Department of Health has confirmed that growth of the Pharmaceutical Benefits Scheme cost…

AustraliaMedicines AustraliaPharmaceuticalPharmaceuticals policyRegulation

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

23-10-2014

The UK’s chancellor of the exchequer, George Osborne, has announced that a partnership led by the Medical…

PharmaceuticalResearchUKUnited KingdomWELLCOME TRUST

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

23-10-2014

Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed…

BelgiumBiotechnologyBoardroomCardio3 BioSciencesCardio3 BioSciences

Biogen Idec third-qtr net rockets 76% but shares slump

Biogen Idec third-qtr net rockets 76% but shares slump

23-10-2014

US biotech firm Biogen Idec saw its share price plunge 7% to $303.51, after its posted third-quarter…

Biogen IdecBiotechnologyFinancialNeurologicalTecfideraUSA

1 to 9 of 96573 results

Back to top